Director/PDMR Shareholding

Savills

10/06/2025 17:57

RNS Number : 2836M

Savills PLC

10 June 2025

 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Deferred Share Awards

 

Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period.  In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trust have effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRs of the Company as follows:

 

Director/ PDMR
Number of Shares Transferred
Number of Shares Disposed
Shareholding following this notification
Shareholding as a % of issued share capital
Mark Ridley (Director)
5,211
94,689
237,065
0.16%
Simon Shaw (Director)
39,500
35,196
222,079
0.15%
Martin Fidden (PDMR)
7,598
-
25,382
0.02%
Alex Jeffrey (PDMR)
120,491
-
238,931
0.17%
Chris Lee (PDMR)
2,166
39,373
121,166
0.08%
Raymond Lee (PDMR)
71,181
-
176,181
0.12%
David Lipson (PDMR)
3,770
3,760
128,886
0.09%
James Sparrow (PDMR)
21,431
19,096
114,450
0.08%

 

The share price on disposal of all shares was £9.625 per share.

 

 

Grant of Deferred Share Awards

 

The Company announces that on 10 June 2025 the grant of the share-based element of 2024 profit share awards has been made under The Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:

 

Director/ PDMR
Number of shares subject to The Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 10 June 2025
Mark Ridley (Director)
105,394
Simon Shaw (Director)
81,120
Alex Jeffrey (PDMR)
57,053
Chris Lee (PDMR)
16,597
James Sparrow (PDMR)
41,493

These awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

 

 

The Company announces that on 10 June 2025 the grant of an award has been made under The Savills Deferred Share Plan (No.2 Plan) to the following PDMR:

PDMR
Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 10 June 2025
Martin Fidden (PDMR)
15,560

This award has a Deferred Period of three years and is subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

 

The Company announces that on 10 June 2025 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan (No.2 Plan) to a PDMR based in the United States of America as follows:

 

PDMR
Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 10 June 2025
David Lipson (PDMR)
68,999

One-third of Mr Lipson's award will vest on each of the three anniversaries subsequent to the date of grant subject to continued employment. The award is subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.

 

Resulting beneficial interests under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan) further to the above notifications are as follows:

Director/ PDMR
Resulting beneficial interest under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan)
Mark Ridley (Director)
267,995
Simon Shaw (Director)
210,101
Martin Fidden (PDMR)
30,635
Alex Jeffrey (PDMR)
183,558
Chris Lee (PDMR)
42,999
Raymond Lee (PDMR)
52,136
David Lipson (PDMR)
181,915
James Sparrow (PDMR)
148,611

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.
Details of the Director/ PDMR
(a)
Name
1. Mark Ridley
2. Simon Shaw
3. Martin Fidden
4. Alex Jeffrey
5. Chris Lee
6. Raymond Lee
7. David Lipson
8. James Sparrow
2.
Reason for the notification
(a)
Position/ status
1. Group Chief Executive/ Director
2. Group Chief Financial Officer/ Director
3. Chief Executive Officer - Asia Pacific (ex-Greater China)/ PDMR
4. Chief Executive Officer - Savills Investment Management/ PDMR
5. Group Legal Director and Company Secretary/ PDMR
6. Chief Executive - Hong Kong, Macau and Greater China/ PDMR
7. Chief Executive Officer - Savills North America/ PDMR
8. Chief Executive Officer, UK & EMEA/ PDMR
(b)
Initial notification/ Amendment
Initial notification
3.
Details of the issuer
(a)
Name
Savills plc
(b)
LEI
213800WXICGMBWHTA933
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the Financial Instrument
Savills plc Ordinary Shares of 2.5p each
(b)
Identification code of the Financial Instrument
GB00B135BJ46
(c)
Nature of the transaction
1) Vesting of awards under the Company's Deferred Share Plans and sale of shares
2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Plans
(d)
Price(s) and volume(s)
Price(s)
Volume(s)
1)
Acquisition
£nil per share
Disposal
£9.625 per share
1. 99,900
2. 74,696
3. 7,598
4. 120,491
5. 41,539
6. 71,181
7. 7,530
8. 40,527
1. 94,689
2. 35,196
3. n/a
4. n/a
5. 39,373
6. n/a
7. 3,760
8. 19,096
2)
£nil per share
1. 105,394
2. 81,120
3. 15,560
4. 57,053
5. 16,597
6. n/a
7. 68,999
8. 41,493
(e)
Aggregated information
- Aggregated volume
- Price
N/A
(f)
Date of the transaction
Vesting of awards and sale of associated shares - 9 June 2025
Grant of awards - 10 June 2025
(g)
Place of the transaction
Vesting of awards - Outside a trading venue
Sale of associated shares - London Stock Exchange
Grant of awards - Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

10 June 2025      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHKZGMVVGVGKZM